Saad, Nizar Y. https://orcid.org/0000-0002-5453-1152
Al-Kharsan, Mustafa
Garwick-Coppens, Sara E.
Chermahini, Gholamhossein Amini
Harper, Madison A.
Palo, Andrew
Boudreau, Ryan L. https://orcid.org/0000-0002-9800-5349
Harper, Scott Q. https://orcid.org/0000-0001-5135-4317
Article History
Received: 30 June 2020
Accepted: 18 November 2021
First Online: 8 December 2021
Competing interests
: N.Y.S. and S.Q.H. declare the following competing interests: provisional patent application N° 63/145,255, covering <i>miR-675</i> upregulation as a therapeutic strategy for FSHD. M.A., S.E.G., G.A.C., M.A.H., A.P., and R.L.B. declare no competing interests.